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Abstract
Caspase recruitment domains (CARDs) are homotypic protein interaction modules that link the stimulus-dependent
assembly of large signaling platforms such as inflammasomes to the activation of downstream effectors that often include
caspases and kinases and thereby play an important role in the regulation of inflammatory and apoptotic signaling
pathways. NOD2 belongs to the NOD-like (NLR) family of intracellular pattern recognition receptors (PRR) and induces
activation of the NF-kB pathway in response to the recognition of bacterial components. This process requires the specific
recognition of the CARD of the protein kinase RIP2 by the tandem CARDs of NOD2. Here we demonstrate that the tandem
CARDs of NOD2 are engaged in an intramolecular interaction that is important for the structural stability of this region.
Using a combination of ITC and pull-down experiments we identify distinct surface areas that are involved in the
intramolecular tandem CARD interaction and the interaction with the downstream effector RIP2. Our findings indicate that
while CARDa of NOD2 might be the primary binding partner of RIP2 the two CARDs of NOD2 do not act independently of
one another but may cooperate to from a binding surface that is distinct from that of single CARDs.
Citation: Fridh V, Rittinger K (2012) The Tandem CARDs of NOD2: Intramolecular Interactions and Recognition of RIP2. PLoS ONE 7(3): e34375. doi:10.1371/
journal.pone.0034375
Editor: Andreas Hofmann, Griffith University, Australia
Received January 26, 2012; Accepted March 1, 2012; Published March 28, 2012
Copyright:  2012 Fridh, Rittinger. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Medical Research Council, UK, grant U117565398. The funder had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: katrin.rittinger@nimr.mrc.ac.uk
¤ Current address: MRC Technology, London, United Kingdom
Introduction
Pattern recognition receptors (PRRs) are utilized by the innate
immune system for the detection of invading pathogens and
danger signals. Detection is based on the recognition of specific,
evolutionary conserved molecular patterns associated with path-
ogens or danger signals in the extracellular space and the
cytoplasm. Extracellular PRRs include the Toll-like receptors
(TLRs) that are also found on lysosomes and endosomes, while
intracellular PRRs encompass the NOD-like receptor (NLR) and
RIG-I like receptor (RLR) families [1–3]. Members of the NLR
family contain a tri-partite domain structure with a C-terminally
located ligand binding domain (LBD) that consists of a varying
number of leucine rich repeats (LRRs). These are flanked by a
centrally located NACHT domain (also referred to as NOD,
nucleotide-binding and oligomerization domain), which oligo-
merizes in a ligand and nucleotide dependent fashion to expose an
N-terminally located effector binding domain (EBD) that mediates
the interaction with downstream effectors to induce activation of
specific signaling processes [4–6].
The interaction of NLRs and RLRs with downstream effectors
is mediated by members of the death fold superfamily, a family of
protein interaction modules that comprises 4 subfamilies: death
domains (DD), death effector domains (DED), caspase recruitment
domains (CARDs) and pyrin domains (PYD) [7,8]. Members of
this protein family form homotypic interactions and play
important roles in the regulation of inflammatory and apoptotic
signaling pathways, often by promoting the assembly of large
multi-protein complexes [9–11]. In general, members of this
superfamily share low sequence homology but adopt a similar
compact, globular fold consisting of a six helix bundle called the
death domain fold [7].
Complexes formed between members of the death domain
subfamily are structurally the best characterized and show how a
given DD is capable of simultaneously engaging up to six binding
partners using three different types of homotypic interactions
referred to as types I, II and III [7,8,12]. Type I interactions are
represented by the complex between the CARDs of Apaf-1 and
procaspase-9, whose crystal structure revealed an interface
involving charge-charge interactions between helices a2 and a3
of Apaf-1 and helices a1 and a4 of caspase-9. In addition, the
interacting surface areas of each protein have a complimentary
shape [13]. A similar mode of interaction has been suggested to
occur between other CARD-CARD complexes [14]. Type II
interactions have first been found in the DD-DD complex formed
between Pelle and Tube [15], and involve helix a4 and the loop
connecting helices a4 and a5 of one domain and the loop
connecting a5 and a6 plus helix a6. Type III interactions have not
been observed in dimeric complexes but exist in the structures of
the PIDDosome, the MyDDosome and the Fas/Fadd DISC [16–
18]. The PIDDosome core complex is formed by five PIDD DDs
and seven RAIDD DDs, in which all DDs exist in a quasi-
equivalent environment and all 3 types of interfaces occur.
Similarly the MyDDosome, formed by MyD88, IRAK-4 and
IRAK-2 shows all three types of interactions to occur suggesting
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e34375that they constitute a common mode of interaction within the DD
superfamily.
At present DDs constitute the only subfamily that has been
shown to be able to promote the formation of large multi-protein
assemblies through homo-oligomerization. In contrast, the CARD
and pyrin domain-containing NLR proteins are believed to form
higher order complexes via oligomerization of their NACHT
domains, while the CARDs or PYDs are assumed to interact in a
1:1 fashion with their downstream effectors [7]. Unlike other
NLRs, NOD2 a protein that regulates nuclear factor kB (NF-kB)
activation and mutations in which have been linked to a
predisposition to Crohn’s disease [19,20] contains 2 CARDs in
tandem (Figure 1A). Ligand sensing by the LRRs of NOD2 and
subsequent NACHT domain-mediated self-oligomerization is
thought to induce the recruitment and polyubiquitination of the
downstream effector kinase RIP2 that in turn activates the NF-kB
signaling pathway and subsequent transcription of proinflamma-
tory genes [21,22]. Complex formation between NOD2 and RIP2
relies on the specific recognition of their respective CARDs, an
interaction which is not understood on a molecular level.
Here we provide the first biophysical characterization of the
tandem CARDs of NOD2. Our study uncovered that the two
CARDs interact with one another in an intramolecular fashion.
We present a biophysical analysis of the isolated and tandem
domains, which is aimed at understanding the molecular basis of
this intramolecular interaction and provide data from a mutational
analysis that suggest that different sites are used for the intra- and
intermolecular CARD-CARD interactions of NOD2.
Results and Discussion
Oligomeric state
The tandem CARDs of NOD2 (Figure 1A) were overexpressed
as a construct comprising amino acids 28–218 that was stable and
monodisperse by dynamic light scattering (DLS). In contrast,
expression of isolated CARDa could not be achieved in E.coli,
despite re-synthesis of the gene optimized for codon-usage in
bacteria and testing of different domain boundaries and bacterial
strains for expression. Therefore, to overcome expression
problems the individual CARDs were purified from a modified
version of the GST-tagged tandem CARD construct. A thrombin-
cleavage site consisting of 5 amino acid residues (VPRGS) was
inserted between CARDa and CARDb at amino acid Leu119.
The resulting GST-fusion protein was cleaved twice during affinity
chromatography, first with thrombin to release CARDb and then
with Precission protease to generate CARDa. Surprisingly, after
cleavage of the linker connecting CARDa and CARDb, a large
proportion of the two domains stayed associated, suggesting that
they may be engaged in an intramolecular interaction.
To assess potential self-association of the tandem as well as
individual CARDs of NOD2 we used equilibrium and sedimen-
tation analytical ultracentrifugation (AUC), respectively. The
equilibrium experiment indicated that the tandem CARD
construct of NOD2 is monomeric with no tendency to associate
into higher order oligomers at the concentrations tested
(Figure 1B). Similarly, sedimentation velocity AUC of the
individual CARDs showed that either domain exists as a monomer
in solution (Figure 1C). However, analysis of a sample containing
equimolar amounts of CARDa and CARDb led to the formation
of a new species with a higher sedimentation coefficient, indicating
that the two CARDs form a 1:1 complex (Figure 1C). Although
these experiments indicate that the CARDs of NOD2 do not have
a high propensity to self-associate, neither as individual domains
nor as the tandem construct, we noticed that at high protein
concentrations (0.5–1.0 mM) there is a tendency of the tandem as
well as isolated CARD constructs to self-associate as observed in
15N HSQC NMR spectra (unpublished data), in line with the
reported homodimerization of a tandem CARDab construct as
seen by yeast two-hybrid analysis [23]. Taken together, these data
indicate that the individual CARDa and CARDb domains interact
with each other in solution, even in the absence of a linker, and
that the tandem CARDs have a tendency to form homo-oligomers
at high protein concentrations.
Fold and stability
To test if CARDa and b act as independent domains or might
stabilize each other we analyzed their fold and stability by circular
dichroism (CD), in tandem and as individual domains. The far-
UV spectra of the individual and tandem domains (Figure 2A)
confirmed the high a-helical content that was expected based on
available crystal and NMR structures of other CARDs. Stability
analysis was carried out by thermal unfolding of the proteins at
222 nm between 5 and 95uC (Figure 2B). Isolated CARDa
unfolded in a reversible manner with a Tm=66.2uC (blue curve)
and CARDb in a non-reversible manner at Tm=38.0uC (red
curve). A comparison of the melting temperatures of the individual
domains to those of other CARDs including NOD1 CARD
(Tm=78.0uC), Apaf-1 CARD (Tm=59.7uC) and procaspase-9
CARD (Tm=53.4uC) (data not shown) highlights that CARDb
unfolds at a particular low temperature. In contrast, the tandem
CARDs of NOD2 unfolded in two non-reversible transitions at
Tm1=55.6uC and Tm2=80.8uC (black curve). Similarly, a
reconstituted complex prepared by mixing equimolar amounts of
CARDa with CARDb underwent two transitions (Figure 2B,
green curve). The first transition occurred at a similar temperature
to that of the tandem construct, around 55uC while the second
transition was observed at a lower temperature than the tandem
construct, but above 60uC. Interestingly, the first transition in the
reconstituted complex as well as in the tandem CARD protein
took place at a higher temperature compared to the computed
mean value of the individual CARDa and CARDb curves (grey
curve), indicating that the more unstable domain, CARDb is
stabilised by CARDa in both cases. Furthermore, the second
transition in the tandem CARD construct was observed at a much
higher temperature compared to that of the reconstituted
complex, suggesting that the covalent link might provide an
additional level of stabilization. Nevertheless, the similar two-step
thermal unfolding curves obtained for the reconstituted complex
and the tandem construct strongly suggest that CARDa and
CARDb interact in the context of the covalently linked wild-type
protein and not only after removal of the linker.
Thermodynamics of the intramolecular CARD-CARD
interaction
To quantify the interaction between CARDa and CARDb we
carried out isothermal titration calorimetry (ITC) experiments.
Titration of CARDa into CARDb at 18, 25 and 30uC resulted in
binding curves that could be fitted to a single site binding model
with a dissociation constant, Kd of 0.9–1.4 mM and a stoichiom-
etry of 1:1 (Figure 3A, Table 1). The heat capacity of complex
formation DCp was determined to be 2450 cal/(mole uC)
(Figure 3B). The linear line indicates that the CARDa-CARDb
interaction is unlikely to be affected by temperature dependent
processes such as thermal unfolding of the proteins, temperature-
induced changes in native protein conformation or changes in
aggregation state [24].
Previous studies on CARD-CARD complexes reported complex
formation to be driven, at least in part, by charge-charge
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CARDa and CARDb of NOD2 has a similar electrostatic
component, ITC titrations were performed at increasing NaCl
concentrations (Table 2). The interaction was weakened but not
disrupted at higher NaCl concentrations, from Kd=1.1 mMa t
50 mM NaCl to Kd=7.1 mM at 1000 mM NaCl (at 30uC). The
change in enthalpy, DH, decreased at higher salt concentrations
(from 29.0 kcal/mol to 22.6 kcal/mol), which is likely to reflect
the breaking of salt bridges. In contrast, the change in entropy,
TDS, increased at higher salt concentrations (from 20.7 cal/
(mol*K) to 4.6 cal/(mol*K)) reflecting the increase in disorder
which is likely to originate from a gain in translational and
rotational freedom of protein side chains as interactions are
disrupted. These data suggest that the intramolecular CARDa-
CARDb interaction has indeed an electrostatic contribution
similar to that observed for intermolecular interactions, but that
van der Waals interactions are also part of the interface.
Intra- versus intermolecular CARD-CARD interactions
Our ITC experiments demonstrate that the CARDs of NOD2
interact with a 1:1 stoichiometry and an affinity of around 1 mM,
comparable to some of the published dissociation constants for
homotypic interactions within the DD superfamily: the RIP2-
caspase1 CARD-CARD complex; Kd of 1.4 mM [25], the Pelle-
Tube DD-DD complex; Kd of around 0.5 mM [26,27] and the
ASC-Pop1 PYD-PYD complex; Kd of 4 mM [28]. In addition, our
own ITC experiments gave a Kd of ,1–4 mM for the CARD-
CARD interaction between Apaf-1 and procaspase-9 at different
temperatures (data not shown).
The fact that CARDa and CARDb are covalently linked in
NOD2 but are able to interact with each other with an affinity
similar to that determined for intermolecular CARD-CARD
complexes is intriguing and raises the question if the binding sites
for interaction with downstream effectors such as RIP2 and each
other are distinct or possibly overlapping and hence must be
subject to some kind of regulatory event. To address this question,
we carried out a mutational analysis of the tandem CARDs in
order to determine the surface areas involved in either interaction.
Mutations were designed based on the structure of the Apaf-1/
procaspase-9 CARD-CARD complex [13] and a mutational study
of the NOD1 and RIP2 interaction [14] and acidic as well as basic
residues in each CARD were targeted. Seven mutations were
introduced into the modified tandem CARD construct (D58A,
E69K, D70A, E72K and R86A in CARDa and D154A and
R182A in CARDb) but only three expressed in sufficient
quantities to allow analysis by ITC (E69K, E72K and R86A).
Interestingly, neither of these mutations in CARDa significantly
affected the strength of the interaction indicating that the targeted
residues are not part of the intramolecular CARD-CARD
interface (Figure 3C, Table 1).
To investigate if these amino acids might instead be important
for the interaction with the downstream effector RIP2, we
attempted to produce a construct of the RIP2 CARD that would
be suitable for ITC studies. Unfortunately though, all tested RIP2
CARD constructs proved to be insoluble. Refolding procedures
allowed us to prepare a protein that contained the expected helical
content as shown by CD spectroscopy but surprisingly was not
able to bind to NOD2 CARDab suggesting that the refolded
protein may not have adopted the correct tertiary structure, an
interpretation that is supported by 1D(
1H)-NMR spectroscopy
(data not shown). Therefore, we decided to study the intermolec-
ular NOD2-RIP2 CARD-CARD interaction by co-expression in
E.coli followed by pull-down experiments. Co-expression of the
GST-tagged tandem CARDs of NOD2 together with the CARD
of RIP2 (aa435–528) fused to an N-terminal solubility enhance-
ment tag, the GB1-tag (protein G B1 domain) and a C-terminal
His-tag followed by pull-down with glutathione sepharose beads
clearly showed a NOD2-RIP2 interaction (Figure 4A). Control
experiments confirmed that there is no unspecific interaction
between RIP2-GB1 and GST (Figure S1A) or between the GB1-
tag and GST-NOD2-CARDab (Figure S1B). Furthermore, the co-
expression system showed a direct interaction between NOD1-
CARD (aa17–138) and RIP2-CARD (see below) but, as a control,
not between caspase-9 CARD (aa1–112) and RIP2-CARD
demonstrating that RIP2 CARD does not interact unspecifically
with other CARDs in our assay.
Mutagenesis of NOD2-CARDab and RIP2-CARD
To investigate the NOD2-RIP2 interaction in more detail and
identify the binding regions involved, a number of residues were
mutated based on sequence conservation within the CARD family
(Figure 5B) and previously reported mutagenesis studies [23,29].
Single-point mutations introduced into the expression plasmid for
wild-type NOD2-CARDab included Q31H, R38A, E69K, E72K,
D58A, D70A, R86A, R87A, A106V (in CARDa) and L145P,
D154A, Q164K, E166K and R182A (in CARDb). GST pull-
down analysis showed that NOD2 CARDab Q31H, E69K, E72K,
R87A, A106V, D154A and Q164K could still interact with RIP2
CARD, similar to the wild-type protein. Mutations D58A, D70A,
L145P E166K and R182A could not be evaluated due to very low
expression levels. In contrast, two mutations, R38A and R86A
located in CARDa, abolished the interaction with RIP2 CARD
(Figure 4B, Table 3). Assuming a scenario in which NOD2 uses
predominantly conserved, basic residues (R38 and R86) to interact
with conserved, acidic residues of RIP2, in analogy with other
CARD-CARD interactions, six additional point mutations were
made in RIP2 CARD. These included D461A, E472A, D473A,
E475A, D492A and D495A. Pull-down analysis with the tandem
CARDs of NOD2 showed that one mutant, D495A could bind
NOD2 as well as wild type while the other five mutants, D461A,
E472A, D473A, E475A and D492A disrupted the interaction with
NOD2 CARDab (Figure 4C, Table 4). In addition to evaluating
the effect of the RIP2 CARD mutants on the interaction with
NOD2, all RIP2 mutants were also tested for their ability to bind
the CARD of NOD1. These experiments gave the same results as
above for five of the mutants: D495A had no effect on binding to
NOD1 CARD while D461A, E472A, E475A and D492A
disrupted the interaction. However, the RIP2 mutant D473A that
disrupted the interaction to NOD2 was able to bind NOD1
CARD (Figure 4D, Table 4). This observation suggests that there
are distinct differences in the interaction of RIP2 with NOD1 or
NOD2 and that their respective CARDs are not interchangeable.
Figure 1. Oligomeric state of the CARDs of NOD2. (A) Schematic representation of the domain structure of human NOD2 and the domain
boundaries of the constructs (tandem CARD, CARDa and CARDb) used in this study. (B) AUC Sedimenation Equilibrium resulted in MW of
22 kDa60.5 kDa for CARDab (calculated MW=22043 Da). The sample was run at three different concentrations and three different speeds (18, 22,
26 kprm). 11 scans were collected over 4 days. (C) AUC Sedimentation Velocity resulted in MW of 10–11 kDa for CARDa (blue line, calculated
MW=11155 kDa) and CARDb (red line, calculated MW=11403 kDa), respectively. Samples were run at OD600,0.5. SedFit was used for data analysis.
A sample containing equal molar amounts of CARDa and CARDb displayed a MW of ,18 kDa.
doi:10.1371/journal.pone.0034375.g001
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e34375Figure 2. Fold and stability of the CARDs of NOD2. (A) Far-UV CD at 250–195 nm showed highly a-helical proteins as reflected in the double
minima at 208 and 222 nm and the strong positive band at 195 nm. Sample concentration was 0.15 mg/ml. The black curve shows the mean residue
ellipticity of NOD2-CARDab, the blue curve of NOD2-CARDa and the red curve of NOD2-CARDb. (B) CD thermal unfolding from 5 to 95uC at 222 nm.
Sample concentration was 0.15 mg/ml. A 2 mm cuvette was used. The black curve represents the mean residue ellipticity of NOD2-CARDab, the blue
curve of CARDa and the red curve of CARDb. The mixture contained 0.075 mg/ml of NOD2-CARDa and NOD2-CARDb, respectively, and is shown in
green. The grey curve represents the computed mean value of NOD2-CARDa and NOD2-CARDb.
doi:10.1371/journal.pone.0034375.g002
Interactions Made by the CARDs of NOD2
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e34375Based on our results we suggest a model, in which RIP2 uses an
acidic surface for the interaction with both, NOD1 and NOD2. In
contrast, a study by Wagner et al [23] predicted NOD2 to use an
acidic surface to interact with RIP2. In their yeast two-hybrid
analysis, two single point mutations in CARDa, E69K and D70A,
as well as a triple mutant (E69K, D70A and E71K) in the tandem
domain of NOD2 failed to bind RIP2 CARD. In the present study
the effect of D70A could not be evaluated due to lack of
expression. E69K on the other hand, showed wild type expression
levels and wild type ability to interact with RIP2 CARD in the
GST-pull down assay implying that E69 does not contribute to the
interaction. In another study, Manon et al [14] concluded that
RIP2 uses a basic surface to bind NOD1. This group used the
NMR-structure of NOD1 and a homology model of RIP2 as the
basis for mutagenesis and based on co-immunoprecipitation and in
vivo NF-kB activation assays identified an acidic patch on NOD1
and basic patch on RIP2 as critical for the interaction. It is not
clear at present if the apparent differences between those studies
and ours are due to the different experimental set-ups used or
reflect true differences in the interaction of RIP2 with NOD1 or
NOD2 and it will require the structures of the respective RIP2/
NOD1 and RIP2/NOD2 complexes to settle this question.
All residues identified in the present study to disrupt the
interaction with RIP2 are located in CARDa, suggesting that
NOD2 primarily uses this domain for the interaction with RIP2
(Figure 5). Such a model agrees with the findings of Rosenstiel et al
[30] who showed, based on co-immunopreciptiation data, that a
short isoform of NOD2, NOD2-S which covers CARDa and only
the first 54 residues of CARDb, is still able to interact with RIP2
CARD. On the other hand a study by Ogura et al [31] suggested
that overexpression of both CARDs is required to induce NF-kB
signaling in the absence of MDP, whereas neither CARDa nor
CARDb alone had this effect. Similarly, Wagner et al [23] found
Figure 3. Thermodynamics of the NOD2 CARDa-CARDb
interaction. (A) ITC measurement of complex formation between
CARDa in the syringe (475 mM) and CARDb in the cell (45 mM). T=25uC.
The binding isotherm was fitted to a one-site binding model with a Kd
of 1.1 mM. A control experiment of CARDa into buffer is shown. (B)
Determination of the heat capacity, DCp. Enthalpies, DH, from CARDa-
CARDb titrations at different temperatures were plotted against the
temperatures. Linear regression analysis gave DCp =dDH/
dT=2450 cal/(mole uC). (C) Effect of CARDa point mutations as
monitored by ITC at 25uC. Titration of CARDa E69K (345 mM) into
CARDb (40 mM) is shown in blue, CARDa E72K (205 mM) into CARDb
(26 mM) in green and CARDa R86A (504 mM) into CARDb (62 mM) in red.
The titrations were performed in the same buffer as in (A).
doi:10.1371/journal.pone.0034375.g003
Table 1. Thermodynamic parameters for the CARDa-CARDb
interaction.
Injectant T N Kd DG DHT DS
(6C) (mM)
(kcal
mol
21)
(kcal
mol
21)
(kcal
mol
21)
CARDa wt 18 0.84 1.08 27.9 22.0 5.9
CARDa wt 25 1.03 0.88 28.3 24.7 3.6
CARDa wt 30 0.91 1.41 28.1 27.4 0.7
CARDa E69K 25 0.94 0.72 28.4 23.8 4.6
CARDa E72K 25 0.81 0.33 28.8 25.2 3.6
CARDa R86A 25 0.91 0.81 28.3 24.8 3.5
doi:10.1371/journal.pone.0034375.t001
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RIP2 CARD in a yeast two-hybrid analysis. However, neither of
these studies investigated the molecular basis for the observation
that both CARDs seem required for the interaction with RIP2 and
asked if the two domains constituted independent binding modules
or may require each other for their stability.
We now show that in addition to recognizing RIP2 the tandem
CARDs interact in an intramolecular fashion with an affinity that
is similar to that identified for other CARD-CARD complexes.
Importantly, we have identified a mutation in NOD2 CARDa,
R86A that fully disrupts the interaction with RIP2 but has no
effect on binding to CARDb. These results strongly indicate that
the surfaces used by NOD2 for intra- and intermolecular
interactions differ and hence are not mutually exclusive.
Furthermore, our thermal unfolding studies showed that the
interaction between the two CARDs significantly increases their
stability, suggesting that the two domains do not act independently
of one another. Based on these observations it is tempting to
speculate that NOD2 may use an extended surface created by the
interaction between the two CARDs to interact with RIP2 in a
manner that is different from typical CARD-mediated interac-
tions, which could explain the discrepancy between our data and
those reported for the NOD1-RIP2 interaction.
Mutual stabilization of tandem protein interaction modules, in
which only one module may be able to interact with ligands, has been
observed in other proteins. For example two of the six PDZ domains
of glutamate receptor-interacting protein (GRIP) pack against each
other to form a stable, supramodular structure that supports binding
of one of the two domains to its target [32]. Similarly, adjacent WW
domains in Suppressor of deltex (SU(dx)) interact with one another
and this arrangement is stabilized upon ligand binding to one of the
tandem domains, while the other is lacking a functional ligand
binding site [33]. Furthermore, adjacent protein interaction modules
may interact to form a higher order structure that has ligand binding
properties that are distinct from those of the individual domains as
observed for the tandem SH3 domains of the NADPH oxidase
subunit p47
phox which form a superSH3 domain that contains only a
single ligand binding site [34].
Conclusions
We provide the first biophysical characterization of the tandem
CARDs that constitute the effector binding domain of NOD2. This
study led to the discovery of an intramolecular interaction between
CARDa and CARDb with a stoichiometry and affinity similar to
previously studied intermolecular CARD-CARD interactions but
occursusingdifferentsitesforintra-andintermolecularinteractions.
Based on mutational analysis we propose a model in which R38 and
R86 located in CARDa of NOD2 interact with a set of acidic
residues on RIP2 CARD suggesting that NOD2 might use CARDa
as the main binding site for the interaction with RIP2. Whether
CARDb participates directly in binding of RIP2 or indirectly, e.g.
by exerting an activating or stabilizing effect on CARDa, needs
further assessment.
Finally, we noticed that the complex between NOD2 CARDab
and RIP2 CARD dissociates after removal of the GST tag and
elution from beads indicating that oligomerization of NOD2 might
be a prerequisite for the formation of a stable complex with RIP2
and could be mimicked by the GST tag in our experiments.
Oligomerization of NLRs is thought to be mediated by their
respective NACHT domains and such an event could bring the
CARDs into close vicinity and promote an interaction which is
otherwise very weak as shown by our AUC and NMR experiments.
A high resolution structure of the NOD2-RIP2 complex is now
required to fully understand the molecular details of this interaction.
Materials and Methods
The cDNA of human NOD2 was a kind gift from T. Segal and
that of RIP2 from D. Abbott. All other cDNAs were purchased
from Source BioScience. Mutagenesis was carried out using the
QuikChange XL site-directed mutagenesis kit (Stratagene). DNA
sequences of all plasmids were verified by DNA sequencing.
Expression and purification of the tandem NOD2-
CARDab construct
The DNA coding for residues 28–218 of NOD2 was cloned into
pGEX-6P1 vector (GE Healthcare). NOD2-CARDab, was
expressed in Escherichia coli Rosetta2 (DE3) cells (Novagen) and
contained a cleavable N-terminal GST-tag. Cells were grown in
LB-media at 37uC and protein expression was induced with
0.3 mM IPTG at 18uC o/n. The recombinant protein was
purified using Glutahione sepharose 4B (GE Healthcare) at
pH 7.5. The GST-tag was removed by Precission protease
cleavage o/n. The eluted NOD CARDab protein was further
purified to homogeneity on a Superdex75 column (GE Health-
care) and concentrated in VivaSpin concentrators.
Expression and purification of the individual CARDs
The tandem NOD2-CARDab expression plasmid was modified
to allow the expression and purification of the individual CARDs
as follows: site-directed mutagenesis was used to insert five residues
(VPRGS) between amino acid 119 (L) and 120 (H) thereby
creating a thrombin cleavage site between the two individual
domains. Expression and purification were performed as described
above but with the following modifications: during affinity
chromatography the GST-fusion protein was cleaved twice on-
column, first with human a-thrombin protease (Cambridge
Biosciences) and then with Precission protease to generate
NOD2-CARDa and NOD2-CARDb, respectively. An anion
exchange step at pH 7.5 (Sepharose Q FF, GE Healthcare) was
required to separate the two CARD domains completely prior to
size exclusion chromatography. The final NOD2-CARDa and
NOD2-CARDb proteins were concentrated to approx. 700 mM
and 400 mM, respectively.
Protein identity of NOD2-CARDab, NOD2-CARDa and
NOD2-CARDb was verified by electrospray mass spectrometry.
Protein concentrations were determined by UV-spectrometry
using calculated extinction coefficients.
Table 2. Salt dependence of the CARDa-CARDb interaction.
Injectant NaCl N Kd DG DHT DS
(mM) (mM)
(kcal
mol
21)
(kcal
mol
21)
(kcal
mol
21)
CARDa wt 50 0.61 1.09 28.3 29.0 20.7
CARDa wt 100 0.91 1.41 28.1 27.4 0.7
CARDa wt 250 0.99 2.99 27.7 25.5 2.2
CARDa wt 500 0.85 6.25 27.2 24.8 2.4
CARDa wt 1000 0.78 7.14 27.1 22.6 4.5
ITC measurements were performed at 30uC in 50 mM Tris-HCl, 2 mM DTT,
pH 7.5 with the ionic strength ranging from 50–1000 mM NaCl. Sample
concentrations were 430–594 mM in the syringe (CARDa) and 38–52 mMi nt h e
cell (CARDb). The low n-value (N=0.6) obtained at 50 mM NaCl may reflect that
CARDb is partially unfolded at this NaCl concentration.
doi:10.1371/journal.pone.0034375.t002
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e34375Figure 4. Complex formation between NOD2 CARDab and RIP2-CARD. (A) NOD2 CARDab with a N-terminal GST-tag and RIP2-CARD
equipped with a N-terminal GB1-tag and a C-terminal His6-tag were co-expressed and pulled-down with glutathione sepharose beads. From left: Lane
1) Protein Marker, GE Healthcare. Lane 2) Soluble lysate. Lane 3) Bead eluate after 3C-protease cleavage. NOD2-CARDab 22.0 kDa and GB1-RIP2 CARD-
His 18.6 kDa are indicated by green and red arrows, respectively. Lane 4) Supernatant bound to beads. GST-NOD2 CARDab 48.5 kDa (green) and GB1-
RIP2 CARD-His 18.6 kDa (red) are indicated by arrows. (B) Effect of NOD2 CARDab single point mutations on RIP2 CARD binding. A representative
cross section of the mutants tested are shown. GST-NOD2 CARDab 48.5 kDa and GB1-RIP2 CARD-His 18.6 kDa are indicated by green and red arrows,
respectively. *=residual expression of GST. (C) Effect of RIP2 CARD single point mutations on NOD2 CARDab binding. A cross section of the mutants
tested are shown. GST-NOD2 CARDab 48.5 kDa and GB1-RIP2 CARD-His 18.6 kDa are indicated by green and red arrows, respectively. (D) Effect of
RIP2 CARD single point mutations on NOD1 CARD binding. A cross section of the mutants tested are shown. GST-NOD1 CARD 40.9 kDa (aa17–138)
and GB1-RIP2 CARD-His 18.6 kDa are indicated by blue and red arrows, respectively.
doi:10.1371/journal.pone.0034375.g004
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Equilibrium AUC and sedimentation velocity studies were
carried out using a Beckman Optima XL-A analytical ultracen-
trifuge. The NOD2 CARDab tandem protein was subjected to
equilibrium AUC using a Beckman An-60 Ti rotor in 50 mM
Tris, 150 mM NaCl, 1 mM TCEP, pH 7.5 at three optical
densities (0.2, 0.4 and 0.6). Equilibrium was reached at three
different speeds (18, 22, 26 kprm) over 4 days. ORIGIN-based
XL-A analysis software was used to determine the molecular mass.
The CARDa and CARDb protein domains of NOD2 were
subjected to sedimentation velocity experiments as individual
samples and as a 1:1 mixture. Experiments were carried out at
optical densities of 0.5 at 280 nm. The software SedFit was used
for data analysis to determine the sedimentation coefficient s, the
frictional coefficient f and estimation of mass.
Circular Dichroism (CD) Spectroscopy
CD spectra were recorded with a JASCO-J715 spectropolar-
imeter. Samples were prepared in 25 mM Tris-buffer pH 8.0. The
protein concentration for far-UV and thermal unfolding was
0.15 mg/mL in a 1 mm cuvette. A reconstituted CARDa-CARDb
complex was prepared by mixing equimolar amounts of NOD2-
CARDa and NOD2-CARDb. Far-UV experiments were run at
20uC. Thermal unfolding/folding was performed at a single
wavelength (222 nm) between 5–95uC. All spectra were corrected
for buffer signals.
Isothermal Titration Calorimetry (ITC)
Complex formation between NOD2-CARDa and NOD2-
CARDb was measured by ITC using a MicroCal VP-ITC
microcalorimeter (GE Healthcare). Samples were dialysed into
ITC buffer (50 mM Tris-HCl, 100 mM NaCl, 2 mM DTT,
pH 7.5). Typically, the sample cell contained NOD2-CARDb at
40–50 mM and the syringe NOD2-CARDa at 400–500 mM.
Titrations with 29 injections of 10 ml were carried out at different
temperatures (12, 15, 25, 30uC) and different NaCl concentrations
(50–1000 mM at 30uC). Heats of dilution were subtracted from
the raw titration data before analysis. Data were fitted by least-
square procedures assuming a one-site binding model using
Microcal Origin version 7.0.
Figure 5. Residues involved in the NOD2-RIP2 interaction. (A) Structure of the CARD-CARD complex between Apaf-1 (light blue) and
procaspase-9 (yellow), pdb ID 3YGS. The relative location of residues that were identified to disrupt the NOD2-RIP2 interaction has been mapped
onto the CARD-CARD structure, based on the alignment shown in (B). These include R38 and R86 (shown in dark blue) located in CARDa of NOD2 that
are shown mapped onto the CARD of procaspase-9 and D461, E472, D473, E475 and D492 in RIP2 (shown in red), mapped onto the CARD of Apaf-1.
(B) The featured residues are highly conserved in CARDs. CARDa R38 and R86 correspond to two (R13 and R56) of the three basic residues in
procaspase-9 (shown in blue) that are crucial for the interaction with Apaf-1. CARDa has no equivalent to the third residue, R52. Conversely, RIP2
CARD D461 corresponds to Apaf-1 D27 and RIP2 E472, D473 and E475 are located in the region of Apaf-1 E40. Apaf-1 D27 and E40 (shown in red) are
both crucial for the interaction with caspase-9.
doi:10.1371/journal.pone.0034375.g005
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Direct CARD-CARD interactions between NOD2 and RIP2
were studied by co-overexpression in E.coli followed by GST-pull
down experiments. Plasmids of NOD2 tandem CARD (aa28–218)
in pGEX-6P1 (amp-res) and RIP2 CARD (aa435–528) in pET-
24b (kan-res) modified with a GB-1 (immunoglobulin binding
domain of Streptococcal protein G) solubility tag were co-
transformed into E.coli Rosetta 2 cells. Overexpression was
performed as described above but in media supplemented with
additional kanamycin. After cell lysis and centrifugation two
overexpressed proteins were present in the soluble fraction:
NOD2-CARDab fused to an N-terminal 3C-protease cleavable
GST-tag and RIP2-CARD equipped with a C-terminal 6xHis-tag
as well as an N-terminal uncleavable GB1-tag. The supernatant
was loaded on gluthatione sepharose beads equilibrated with lysis
buffer pH 8.0 and after washing the beads were boiled in SDS
loading buffer and analyzed by SDS–polyacrylamide gel electro-
phoresis. Alternatively, the GST tag was cleaved on-column with
Precission protease and the eluate analyzed by SDS-PAGE. The
co-expression system was also used to study RIP2-CARD
interactions with NOD1 CARD (aa17–138) and caspase-9 CARD
(aa1–112), both expressed as N-terminal GST-fusion proteins.
Control experiments were performed by co-expression of the GB-1
tag alone in pET24b with the NOD2-CARDab tandem construct
as well as with the pGEX-6P1 vector. No interaction was detected
between the GB-1 tag and NOD2-CARDab or between GB-1 and
GST.
Supporting Information
Figure S1 Control gels for GST-pull down experiments.
(A) RIP2 CARD with a GB1 tag (RIP2-GB1) does not bind GST.
Lane 1) Protein Marker, Sigma. Lane 2) Supernatant. RIP2-GB1
co-expressed with GST only. GST 26 kDa and RIP2-GB1
18.6 kDa are indicated by arrows. Lane 3) Supernatant bound
to beads. Only GST is present. (B) The GB1 tag does bind GST-
NOD2-CARDab. Lane 1) Protein Marker, GE Healthcare. Lane
2) Supernatant. GB1 8.6 kDa is indicated by arrow. Lane 3)
Supernatant bound to beads. GST-NOD2-CARDab 48.5 kDa
and GST 25.5 kDa are indicated by arrows. No GB1 is present.
(TIF)
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